Humana (NYSE:HUM) Trading Down 0.2%

Shares of Humana Inc. (NYSE:HUMGet Free Report) dropped 0.2% during trading on Wednesday . The company traded as low as $342.49 and last traded at $343.97. Approximately 357,920 shares traded hands during trading, a decline of 82% from the average daily volume of 1,944,811 shares. The stock had previously closed at $344.50.

Wall Street Analyst Weigh In

HUM has been the topic of a number of research reports. Bank of America restated a “neutral” rating and set a $342.00 target price (down previously from $470.00) on shares of Humana in a report on Tuesday, April 2nd. Mizuho dropped their target price on shares of Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, January 26th. Jefferies Financial Group dropped their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Cantor Fitzgerald dropped their target price on shares of Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Finally, Royal Bank of Canada dropped their target price on shares of Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $424.50.

Read Our Latest Stock Report on HUM

Humana Stock Performance

The business’s fifty day moving average price is $321.79 and its 200-day moving average price is $380.08. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The stock has a market cap of $41.83 billion, a PE ratio of 21.41, a P/E/G ratio of 1.98 and a beta of 0.50.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the firm posted $9.38 EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.02%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction dated Tuesday, February 20th. The shares were purchased at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.29% of the company’s stock.

Hedge Funds Weigh In On Humana

Institutional investors have recently made changes to their positions in the business. Rakuten Securities Inc. bought a new stake in Humana during the 4th quarter worth approximately $25,000. Gradient Investments LLC raised its stake in Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the period. Cetera Trust Company N.A bought a new stake in Humana during the 4th quarter worth approximately $28,000. Private Wealth Management Group LLC bought a new stake in Humana during the 4th quarter worth approximately $32,000. Finally, Carolinas Wealth Consulting LLC raised its stake in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after acquiring an additional 74 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.